Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -203.50% is in line with its 5-year average of -225.23%, near the high end of its 5-year range (-519.89%–-86.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.15% below its 12-month average of -179.84%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -203.50%.
RETURN ON INVESTED CAPITAL (ROIC)
-203.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-179.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-248.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-225.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-207.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-13.15%
CURRENT VS 3Y AVG
+18.17%
CURRENT VS 5Y AVG
+9.65%
CURRENT VS 10Y AVG
+1.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-470.90%
vs the sector median at left
Dare Bioscience, Inc.
Market Cap
$12.47M
Return on Invested Capital (ROIC)
-203.50%
TTM Avg
-179.84%
3Y Avg
-248.69%
5Y Avg
-225.23%
Market Cap
$12.46M
Return on Invested Capital (ROIC)
-74.94%
TTM Avg
-273.26%
3Y Avg
-277.38%
5Y Avg
-186.51%
Market Cap
$12.43M
Return on Invested Capital (ROIC)
-784.16%
TTM Avg
-160.08%
3Y Avg
-118.03%
5Y Avg
-103.52%
Market Cap
$12.63M
Return on Invested Capital (ROIC)
-43.31%
TTM Avg
-42.56%
3Y Avg
-55.36%
5Y Avg
-44.03%
Market Cap
$12.25M
Return on Invested Capital (ROIC)
-358.04%
TTM Avg
-62.86%
3Y Avg
-6481.16%
5Y Avg
-4328.67%
Market Cap
$12.24M
Return on Invested Capital (ROIC)
-86.22%
TTM Avg
-227.24%
3Y Avg
-220.51%
5Y Avg
-220.51%
Market Cap
$12.77M
Return on Invested Capital (ROIC)
-889.92%
TTM Avg
-97.42%
3Y Avg
-82.73%
5Y Avg
-70.79%
Market Cap
$12.03M
Return on Invested Capital (ROIC)
-19.53%
TTM Avg
-16.13%
3Y Avg
-40.26%
5Y Avg
-33.39%
Market Cap
$11.83M
Return on Invested Capital (ROIC)
-32.27%
TTM Avg
-112.80%
3Y Avg
-113.13%
5Y Avg
-94.20%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | $12.47M | -203.50% | -179.84% | -248.69% | -225.23% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.46M | -74.94% | -273.26% | -277.38% | -186.51% |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.43M | -784.16% | -160.08% | -118.03% | -103.52% |
| Cytosorbents Corporation (CTSO)vs › | $12.63M | -43.31% | -42.56% | -55.36% | -44.03% |
| Lantern Pharma Inc. (LTRN)vs › | $12.25M | -358.04% | -62.86% | -6481.16% | -4328.67% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.24M | -86.22% | -227.24% | -220.51% | -220.51% |
| Passage Bio, Inc. (PASG)vs › | $12.77M | -889.92% | -97.42% | -82.73% | -70.79% |
| IRIDEX Corporation (IRIX)vs › | $12.03M | -19.53% | -16.13% | -40.26% | -33.39% |
| Biofrontera Inc. (BFRI)vs › | $11.83M | -32.27% | -112.80% | -113.13% | -94.20% |
| IN8bio, Inc. (INAB)vs › | $13.33M | -91.74% | -119.31% | -112.64% | -88.90% |
ROIC
-203.5%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -203.50% |
| 2026-03-31 | -178.41% |
| 2025-12-31 | -154.20% |
| 2025-09-30 | -183.27% |
| 2024-09-30 | -473.88% |
| 2024-06-30 | -298.90% |
| 2023-03-31 | -519.89% |
| 2022-12-31 | -257.00% |
| 2022-09-30 | -89.69% |
| 2022-06-30 | -86.72% |
| 2022-03-31 | -121.30% |
| 2021-12-31 | -98.27% |
| 2021-09-30 | -115.38% |
| 2021-06-30 | -372.88% |
| 2021-03-31 | -699.36% |
| 2020-06-30 | -653.85% |
| 2020-03-31 | -282.19% |
| 2019-12-31 | -783.71% |
| 2019-09-30 | -674.45% |
| 2019-06-30 | -239.19% |
| 2019-03-31 | -306.96% |
| 2018-12-31 | -250.63% |
| 2018-09-30 | -240.42% |
| 2018-06-30 | -178.21% |
| 2018-03-31 | -117.73% |
| 2017-12-31 | -84.10% |
| 2017-09-30 | -29.20% |
| 2017-06-30 | -305.69% |
| 2017-03-31 | -264.20% |
| 2016-12-31 | -127.54% |
| 2016-09-30 | -131.57% |
| 2016-06-30 | -99.56% |
| 2016-03-31 | -76.63% |
| 2015-12-31 | -53.45% |
| 2015-09-30 | -46.85% |
| 2015-06-30 | -35.91% |
| 2015-03-31 | -45.56% |
| 2014-12-31 | -41.85% |
| 2014-09-30 | -28.01% |
| 2014-06-30 | -21.29% |
| 2014-03-31 | -162.99% |
| 2013-12-31 | -409.50% |
